Literature DB >> 7521195

Analysis of factors affecting uptake of Tc-99m Sn-N-pyridoxyl-5-methyltryptophan by hepatocellular carcinoma.

Y Hasegawa1, S Nakano, T Sobue, M Fujita, S Ishiguro, Y Sasaki, S Imaoka, S Tanaka, H Kasugai, A Inoue.   

Abstract

We performed Tc-99m PMT imaging in 176 patients with HCC and evaluated factors affecting 99mTc-PMT uptake by HCC with a logistic model. The probability of HCC showing increase in uptake of the radioisotope was 104.6 times higher in patients with the Ed I type than in those with the Ed III type and 12.1 times higher in patients with a tumor diameter of 5.0-7.9 cm than in those with a tumor diameter of 2.0-5.0 cm. Among the other variables, the serum AFP level and sex were suggested to have effects similar to those of the tumor size on Tc-99m PMT uptake by HCC. The grade of morphological differentiation of the tumor was therefore most markedly related to Tc-99m PMT uptake.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7521195     DOI: 10.1007/bf03165019

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  17 in total

1.  Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil.

Authors:  H Kasugai; J Kojima; M Tatsuta; S Okuda; Y Sasaki; S Imaoka; M Fujita; S Ishiguro
Journal:  Gastroenterology       Date:  1989-10       Impact factor: 22.682

2.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

3.  [Can fluorodeoxyglucose-positron emission tomography evaluate the functional differentiation of hepatocellular carcinoma].

Authors:  K Enomoto; T Fukunaga; S Okazumi; T Asano; T Kikuchi; H Yamamoto; T Nagashima; K Isono; H Itoh; K Imazeki
Journal:  Kaku Igaku       Date:  1991-11

4.  Characterization of primary hepatocellular carcinomas and initial transplant generations.

Authors:  F F Becker; K M Klein; S R Wolman; R Asofsky; S Sell
Journal:  Cancer Res       Date:  1973-12       Impact factor: 12.701

5.  The spectrum of angiographic findings in hepatoma.

Authors:  S R Reuter; H C Redman; D B Siders
Journal:  Radiology       Date:  1970-01       Impact factor: 11.105

6.  Hepatic artery embolization in 120 patients with unresectable hepatoma.

Authors:  R Yamada; M Sato; M Kawabata; H Nakatsuka; K Nakamura; S Takashima
Journal:  Radiology       Date:  1983-08       Impact factor: 11.105

7.  Technetium-99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma: relationship between detectability and tumor differentiation.

Authors:  X Calvet; F Pons; J Bruix; C Bru; F Lomeña; R Herranz; M Brugera; R Faus; J Rodes
Journal:  J Nucl Med       Date:  1988-12       Impact factor: 10.057

8.  Early hepatocellular carcinoma: MR imaging.

Authors:  Y Muramatsu; S Nawano; K Takayasu; N Moriyama; T Yamada; S Yamasaki; S Hirohashi
Journal:  Radiology       Date:  1991-10       Impact factor: 11.105

9.  Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study.

Authors:  Y F Liaw; D I Tai; C M Chu; D Y Lin; I S Sheen; T J Chen; C C Pao
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

10.  Specific diagnosis of hepatoma using 99mTc-HIDA and other radionuclides.

Authors:  V W Lee; J H Shapiro
Journal:  Eur J Nucl Med       Date:  1983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.